Summary

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published: September 15, 2023
doi:

Summary

This study presents a surgical porcine model of chronic myocardial ischemia due to progressive coronary artery stenosis, resulting in impaired cardiac function without infarction. Following ischemia, animals undergo off-pump coronary artery bypass graft with epicardial placement of stem cells-derived exosomes-laden collagen patch. This adjunctive therapy improves myocardial function and recovery.

Abstract

Chronic myocardial ischemia resulting from progressive coronary artery stenosis leads to hibernating myocardium (HIB), defined as myocardium that adapts to reduced oxygen availability by reducing metabolic activity, thereby preventing irreversible cardiomyocyte injury and infarction. This is distinct from myocardial infarction, as HIB has the potential for recovery with revascularization. Patients with significant coronary artery disease (CAD) experience chronic ischemia, which puts them at risk for heart failure and sudden death. The standard surgical intervention for severe CAD is coronary artery bypass graft surgery (CABG), but it has been shown to be an imperfect therapy, yet no adjunctive therapies exist to recover myocytes adapted to chronic ischemia. To address this gap, a surgical model of HIB using porcine that is amenable to CABG and mimics the clinical scenario was used. The model involves two surgeries. The first operation involves implanting a 1.5 mm rigid constrictor on the left anterior descending (LAD) artery. As the animal grows, the constrictor gradually causes significant stenosis resulting in reduced regional systolic function. Once the stenosis reaches 80%, the myocardial flow and function are impaired, creating HIB. An off-pump CABG is then performed with the left internal mammary artery (LIMA) to revascularize the ischemic region. The animal recovers for one month to allow for optimal myocardial improvement prior to sacrifice. This allows for physiologic and tissue studies of different treatment groups. This animal model demonstrates that cardiac function remains impaired despite CABG, suggesting the need for novel adjunctive interventions. In this study, a collagen patch embedded with mesenchymal stem cell (MSC)-derived exosomes was developed, which can be surgically applied to the epicardial surface distal to LIMA anastomosis. The material conforms to the epicardium, is absorbable, and provides the scaffold for the sustained release of signaling factors. This regenerative therapy can stimulate myocardial recovery that does not respond to revascularization alone. This model translates to the clinical arena by providing means of physiological and mechanistic explorations regarding recovery in HIB.

Introduction

Globally, severe CAD affects over a hundred million patients, and although the mortality rate has decreased, it remains one of the leading causes of death1,2. CAD has a wide clinical spectrum from myocardial infarction (MI) to ischemia with preserved viability. Most pre-clinical research focuses on MI, characterized by the presence of infarcted tissue as it is possible to study in small and large animal models. However, that model does not address patients with preserved viability and amenable to revascularization. Most patients undergoing CABG have decreased blood supply and limited function while maintaining variability in contractile reserve and viability3. Without treatment, these patients can progress to advanced heart failure and sudden death, especially during increased workload4. Among these patients, coronary artery bypass graft (CABG) is an effective therapy but may not result in complete functional recovery5. Importantly, diastolic dysfunction, which is a marker for worse clinical outcomes, fails to recover after revascularization suggesting the need for novel adjuvant therapies during CABG6,7. Currently, there are no clinically available adjuvant interventions used with CABG to restore cardiomyocytes to full functional capacity. This is a major therapeutic gap given that many patients progress to advanced heart failure despite appropriate revascularization8.

An innovative porcine model of chronic myocardial ischemia that is amenable to CABG, to mimic clinical CAD experience was created9. Swine provide a good model of heart disease over other large animals as they do not have epicardial bridging collaterals so stenosis of the LAD alone results in regional ischemia10. In this study, 16-week-old female Yorkshire-Landrace pigs were used. In this model, the LAD was revascularized with off-pump CABG using the left internal mammary artery (LIMA) graft (Supplementary Table 1). Percutaneous coronary intervention (PCI) is not possible to open the stenosis as the constrictor is a rigid device. Cardiac magnetic resonance imaging (MRI) is used to assess global and regional function, coronary anatomy, and tissue viability. Cardiac MRI analysis showed diastolic function, characterized by peak filling rate (PFR) remains impaired despite CABG6. The mechanism of diastolic dysfunction likely relates to impaired mitochondrial bioenergetics and collagen formation in HIB that persist following CABG11.

Mesenchymal stem cells (MSC) provide therapeutic signaling through exosomes to improve myocardial recovery when applied during CABG. In this swine model and parallel in vitro studies, it was shown that placement of an epicardial MSC vicryl patch during CABG recovers contractile function with increase in key mitochondrial proteins namely PGC-1α12, an important regulator of mitochondrial energy metabolism13. The in vitro model allowed us to investigate the signaling mechanism of MSCs on impaired mitochondrial function. Exosomes are secreted stable microvesicles (50-150 nm) that contain protein or nucleic acids including microRNA (miRNA)14. Recent in vitro data suggest that MSC-derived exosomes are an important signaling mechanism necessary for recovery of mitochondrial respiration.

Stem cell derived exosomes are promising adjunctive therapeutics as they are readily accessible, can be commercially produced, and lack ethical conflicts. In consideration of clinical translation, a collagen patch embedded with MSC-derived exosomes was created that can be surgically sutured to the hibernating region of myocardium. It was demonstrated that there is sustained delivery of exosomes using this patch and it provides a cell-free regenerative therapy with paracrine signaling mechanism that targets mitochondrial recovery and enhance mitochondrial biogenesis15. This procedure provides the pre-clinical model to study the impact of MSC-derived therapies to improve cardiac function by means of enhancing mitochondrial function and reducing inflammation at the time of revascularization and reverse the myocyte adaptations to chronic ischemia.

In this study, a surgical method of off-pump CABG using LIMA to LAD anastomosis to bypass the area of proximal LAD stenosis mimicking the standard treatment for patients with CAD is shown. As an adjunctive therapy with CABG, the surgical application of MSC-derived exosome embedded collagen patch on the ischemic region of the myocardium was demonstrated. This surgical model can be used to study the physiologic responses to the paracrine effect seen with use of an exosome patch as well as the molecular mechanisms of recovery.

Protocol

The Institutional Animal Care and Use Committees (IACUC) of the Minneapolis VA Medical Center and the University of Minnesota have approved all of the animal studies. The current National Institutes of Health (NIH) guidelines for the use and care of laboratory animals were followed. 1. Isolation of mesenchymal stem cells and preparation and characterization of exosomes Isolation of bone marrow derived mesenchymal stem cells (MSCs) Obtain 30-50 mL of ste…

Representative Results

Following revascularization, coronary angiography is performed to assess for LAD stenosis (greater than 80%) and patency of the LIMA-LAD graft (Figure 1). Four weeks following the revascularization surgery and placement of the exosome-laden collagen patch, cardiac MRI is performed to assess for systolic and diastolic function of the heart at rest and under stress using low-dose dobutamine infusion at 5µg/kg/min. Systolic function is analyzed by measuring wall thickness percentage (wall …

Discussion

This study presents the first porcine model of chronically ischemic myocardium, in which it was shown that treatment with an MSC-derived exosome laden collagen patch during surgical revascularization recovers diastolic and systolic function upon inotropic stimulation potentially by targeting mitochondrial recovery. Previously, it was demonstrated that in a large animal model of HIB the diastolic and systolic function, as measured by cardiac MRI, remains impaired and only slightly improves with revascularization without c…

Divulgations

The authors have nothing to disclose.

Acknowledgements

This work was supported by the VA Merit Review #I01 BX000760 (RFK) from the United States (U.S.) Department of Veterans Affairs BLR&D and U.S. Department of Veterans Affairs grant #I01 BX004146 (TAB). We also gratefully acknowledge the support of the University of Minnesota Lillehei Heart Institute. The contents of this work do not represent the views of the U.S. Department of Veterans Affairs of the United States Government.

Materials

5 Ethibond Ethicon MG46G Suture
# 40 clipper blade Oster 078919-016-701 Remove hair from surgery sites
0 Vicryl Ethicon J208H Suture
1 mL Syringe Medtronic/Covidien 1188100777 Administer injectable agents
1" medical tape Medline MMM15271Z Secure wound dressing and IV catheters
1000mL 0.9% Sodium chloride Baxter 2B1324X IV replacement fluid
12 mL Syringe Medtronic/Covidien 8881512878 Administer injectable agents
18 ga needles BD 305185 Administration of injectable agents
20 ga needles BD 305175 Administration of injectable agents
20 mL Syringe Medtronic/Covidien 8881520657 Administer injectable agents
2-0 Vicryl Ethicon J317H Suture
250 mL 0.9% saline Baxter  UE1322D Replacement IV Fluid
3 mL Syinge Medtronic/Covidien 1180300555 Administer injectable agents
3-0 Vicryl Ethicon VCP824G Suture
36” Pressure monitoring tubing Smith’s Medical MX563 Connect art. Line  to transducer
4.0 mm ID endotracheal tube Medline DYND43040 Establish airway for Hibernation
4-0 Tevdek II Strands Deknatel 7-922 Suture to secure constrictor around LAD
48” Pressure monitoring tubing Smith’s Medical MX564 Connect art. Line  to transducer
500mL 0.9% Sodium chloride Baxter 2B1323Q Drug delivery, Provide mist for Blower Mister
6  mL Syringe Medtronic/Covidien 1180600777 Administer injectable agents
6.0 mm ID endotracheal tube Mallinckrodt 86049 Establish airway for Revasc,MRI and Termination
6.5 mm ID endotracheal tube Medline DYND43065 Establish airway for Revasc,MRI and Termination
6” pressure tubing line Smith’s Medical MX560 Collect bone marrow
60 mL Syringe Medtronic/Covidien 8881560125 Administer injectable agents
7.0 mm ID endotracheal tube Medline DYND43070 Establish airway for Revasc,MRI and Termination
7-0 Prolene Ethicon M8702 Suture
Advanced DMEM (1X) ThermoFisher Scientific 12491023
Alcohol Prep pads MedSource MS-17402 Skin disinfectant
Amicon Ultra-15 Centrifugal Filter Unit Millipore Sigma UFC910024
Anesthesia Machine Drager Fabious Trio maintains general anesthesia
Anesthesia Machine + ventilator DRE Drager- Fabius Tiro DRE0603FT Deliver Oxygen and inhalant to patient
Anesthesia Monitor Phillips  Intellivue MP70 Multiparameter for patient safety
Arterial Line Kit Arrow ASK-04510-HF Femoral catheter for blood pressure monitoring
Artificial Tears Rugby 0536-1086-91 Lubricate eyes to prevent corneal drying
Bair Hugger 3M Model 505 Patient Warming system
Basic pack Medline DYNJP1000 Sterile drapes and table cover
Blood Collection Tubes- green top Fisher Scientific 02-689-7 Collect microsphere blood samples
Blower Mister Kit Medtronic/Covidien 22120 Clears surgical field for vessel anastomosis
BODIPY TR Ceramide ThermoFisher Scientific D7540
Bone marrow needle- 25mm 15 ga IO needle Vidacare 9001-VC-005 Collect bone marrow
Bone Wax Medline ETHW31G Hemostasis of cut bone
Bovie Cautery hand piece Covidien E2516 Hemostasis
Bupivicaine Pfizer 00409-1161-01 Local Anesthetic
Buprenorphine 0.3 mg/mL Sigma Aldrich B9275 Pre operative Analgesic for survivial procedures
Cell Scrapers Corning 353085
Cephazolin 1 gr Pfizer 00409-0805-01 Antibiotic
Chest Tube Covidien 8888561043 Evacuates air from chest cavity
Cloroprep Becton Dickenson 260815 Surgical skin prep
Corning bottle-top vacuum Filter System (500mL) Millipore Sigma 430758
CPT tube BD 362753 MSC isolation from bone marrow
Delrin Constrictor U of MN Custom made Creates stenosis of LAD
Dermabond Ethicon DNX12 Skin adhesive
DMEM (1X) Dulbecco's Modified Eagle Medium, HEPES ThermoFisher Scientific 12430062
Dobutamine 12.5 mg/mL Pfizer 00409-2344-01 Increases blood pressure and heart rate during the second microsphere blood collection
ECG Pads DRE 1496 Monitor heart rhythm
Exosome-Depleted FBS ThermoFisher Scientific A2720801
Falcon Disposable Polystyrene Serological Pipets, Sterile, 10mL Fisher Scientific 13-675-20
Femoral and carotid introducer Cordis- J&J 504606P femoral and carotis cannulas
Fetal Bovine Serum, Heat Inactivated, Gibco FBS ThermoFisher Scientific 16140089
Flo-thru 1.0 Baxter FT-12100 used to anastomos LIMA to L
Flo-thru 1.25 Baxter FT-12125 FT-12125
Flo-thru 1.5 Baxter FT-12150 FT-12150
Flo-thru 2.0 Baxter FT-12200 FT-12200
GlutaMAX Supplement ThermoFisher Scientific 35050061
Hair Clipper Oster 078566-011-002 Remove hair from surgery sites
Helistat collagen sponge McKesson 570973 1690ZZ Sponge for embedding exosomes
Heparin Pfizer  0409-2720-03 anticoaggulant
Histology Jars Fisher Scientific 316-154 Formalin for tissue samples
HyClone Characterized Fetal Bovine Serum (FBS) Cytiva SH30071.03
Hypafix BSN Medical 4210 Secure wound dressing and IV catheters
Isoflurane Sigma Aldrich CDS019936 General Anesthestic- Inhalant
IV Tubing for Blower Mister Carefusion 42493E Adapts to IV Fluids for Blower/Mister
Jelco 18 ga IV catheter Smiths medical 4054 IV access in Revasc, MRI and Term
Lidocaine 2% Pfizer 00409-4277-01 Local Anesthetic/ antiarrthymic
Ligaclips Ethicon MSC20 Surgical Staples for LIMA takedown
Long blade for laryngoscope DRE 12521 Allows for visualization of trachea for intubation
Meloxicam 5 mg/mL Boehringer Ingelheim 141-219 Post operative Analgesic
Microsphere pump Collect blood samples from femoral introducer
Monopolar Cautery Covidien Valleylab™ FT10 Hemostasis
Nanosight NS 300 Malvern Panalytical MAN0541-03-EN
NTA 3.1.54 software Malvern Panalytical MAN0520-01-EN-00
OPVAC Synergy II Terumo Cardiovascular System 401-230 Heart positioner and Stabilizer
Oxygen Tank E cylinder various various Used for Blower Mister if anesthesia machine doesn't have auxiliary flow meter
PBS, pH 7.2 ThermoFisher Scientific 20012050
Penicillin-Streptomycin-Neomycin (PSN) Antibiotic Mixture ThermoFisher Scientific 15640055
Pigtail 145 catheter 6 French Boston Scientific 08641-41 Measure LV pressures
Pressure Transducer various Must adapt to anesthesia monitor Monitor direct arterial pressures
Propofol Diprivan 269-29 Induction agent
Roncuronium Mylan 67457-228-05 Neuromuscular blocking agent
SR Buprenorphine 10 mg/mL Abbott Labs NADA 141-434 Post operative Analgesic
Sterile Saline 20 mL Fisher Scientific 20T700220 Flush for IV catheters
Sternal Saw/ Necropsy Saw Thermo Fisher 812822 Used to open chest cavity
Stop Cocks Smith Medical MX5311L 2 to connect to pig tail
Succinylcholine 20 mg/mL Pfizer 00409-6629-02 Neuromuscular blocking agent
Suction  tubing Medline DYND50223
Suction Container Medline DYNDCL03000
Surgery pack with chest retractor various See pack list Femoral cut down and median sternotomy
Surgical Instruments various See pack list Femoral and carotid cutdowns and sternotomy
Surgical Spring Clip Applied Medical A1801 Clamp end of LIMA after takedown
Syringe pump Harvard Delivers IV Dobutamine infusion
SYTO RNASelect Green Fluorescent cell Stain – 5 mM Solution in DMSO Millipore Sigma S32703
Telazol 100 mg/mL Fort Dodge 01L60030 Pre operative Sedative
Telpha pad Covidien 2132 Sterile wound dressing
Timer Time collection of blood samples
Total Exosome Isolation Reagent (from cell culture media) ThermoFisher Scientific 4478359
TPP Tissue Culture Flask, T75, Filter Cap w/ 0.22uM PTFE ThermoFisher Scientific TP90076
Triple Antibiotic Ointment Johnson & Johnson 23734 Topical over wound
Vicryl mesh Ethicon VKML Patch for epicardial cell application
Vortex Mix microspheres
Xylazine 100 mg/mL Vedco 468RX Pre operative Sedative/ analgesic

References

  1. Dai, H., et al. Global, regional, and burden of ischaemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017. European heart journal. Quality of care & clinical outcomes. 8 (1), 50-60 (2022).
  2. Tsao, C. W., et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 145 (8), e153-e639 (2022).
  3. Rahimtoola, S. H. The hibernating myocardium. American Heart Journal. 117 (1), 211-221 (1989).
  4. Canty, J. M., Fallavollita, J. A. Hibernating myocardium. Journal of Nuclear Cardiology. 12 (1), 104-119 (2005).
  5. Page, B. J., et al. Revascularization of chronic hibernating myocardium stimulates myocyte proliferation and partially reverses chronic adaptations to ischemia. Journal of the American College of Cardiology. 65 (7), 684-697 (2015).
  6. Aggarwal, R., et al. Persistent diastolic dysfunction in chronically ischemic hearts following coronary artery bypass graft. The Journal of Thoracic and Cardiovascular Surgery. 165 (6), e269-e279 (2023).
  7. Olsen, F. J., et al. Prognostic Value and Interplay Between Myocardial Tissue Velocities in Patients Undergoing Coronary Artery Bypass Grafting. The American Journal of Cardiology. 144, 37-45 (2021).
  8. Virani, S. S. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 143 (8), e254-e743 (2021).
  9. Hocum Stone, L., et al. Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery. Journal of Visualized Experiments:JoVE. (133), e57229 (2018).
  10. White, F. C., Carroll, S. M., Magnet, A., Bloor, C. M. Coronary collateral development in swine after coronary artery occlusion. Circulation Research. 71 (6), 1490-1500 (1992).
  11. Righetti, A., et al. Interventricular septal motion and left ventricular function after coronary bypass surgery: evaluation with echocardiography and radionuclide angiography. The American Journal of Cardiology. 39 (3), 372-377 (1977).
  12. Hocum Stone, L. L., et al. Recovery of hibernating myocardium using stem cell patch with coronary bypass surgery. The Journal of Thoracic and Cardiovascular Surgery. 62 (1), e3-e16 (2021).
  13. Puigserver, P., Spiegelman, B. M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocrine Reviews. 24 (1), 78-90 (2003).
  14. Henning, R. J. Cardiovascular Exosomes and MicroRNAs in Cardiovascular Physiology and Pathophysiology. Journal of Cardiovascular Translational Research. 14 (2), 195-212 (2021).
  15. Chen, Y., Liu, Y., Dorn, G. W. 2nd. Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circulation Research. 109 (12), 1327-1331 (2011).
  16. Pittenger, M. F., Martin, B. J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circulation Research. 95 (1), 9-20 (2004).
  17. Campos-Silva, C., et al. High sensitivity detection of extracellular vesicles immune-captured from urine by conventional flow cytometry. Scientific Reports. 9 (1), 2042 (2019).
  18. Hocum Stone, L. L., et al. Magnetic resonance imaging assessment of cardiac function in a swine model of hibernating myocardium 3 months following bypass surgery. The Journal of Thoracic and Cardiovascular Surgery. 153 (3), 582-590 (2017).
  19. Stone, L. L. H., et al. Mitochondrial Respiratory Capacity is Restored in Hibernating Cardiomyocytes Following Co-Culture with Mesenchymal Stem Cells. Cell Medicine. 11, 2155179019834938 (2019).
  20. Lamy, A., et al. Skeletonized vs Pedicled Internal Mammary Artery Graft Harvesting in Coronary Artery Bypass Surgery: A Post Hoc Analysis From the COMPASS Trial. JAMA Cardiology. 6 (9), 1042-1049 (2021).
  21. Shim, J. K., Choi, Y. S., Yoo, K. J., Kwak, Y. L. Carbon dioxide embolism induced right coronary artery ischaemia during off-pump obtuse marginalis artery grafting. European Journal of Cardio-Thoracic Surgery. 36 (3), 598-599 (2009).
  22. Aklog, L. Future technology for off-pump coronary artery bypass (OPCAB). Seminars in Thoracic and Cardiovascular Surgery. 15 (1), 92-102 (2003).
  23. Hou, D., et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation. 112 (9 Suppl), I150-I156 (2005).
  24. Gallet, R., et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. European Heart Journal. 38 (3), 201-211 (2017).
check_url/fr/65553?article_type=t

Play Video

Citer Cet Article
Aggarwal, R., Shao, A., Potel, K. N., Hocum Stone, L., Swingen, C., Wright, C., McFalls, E. O., Butterick, T. A., Kelly, R. F. Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft. J. Vis. Exp. (199), e65553, doi:10.3791/65553 (2023).

View Video